LST8_HUMAN - dbPTM
LST8_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LST8_HUMAN
UniProt AC Q9BVC4
Protein Name Target of rapamycin complex subunit LST8
Gene Name MLST8
Organism Homo sapiens (Human).
Sequence Length 326
Subcellular Localization Cytoplasm.
Protein Description Subunit of both mTORC1 and mTORC2, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino acids. Growth factor-stimulated mTORC1 activation involves a AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Within mTORC1, LST8 interacts directly with MTOR and enhances its kinase activity. In nutrient-poor conditions, stabilizes the MTOR-RPTOR interaction and favors RPTOR-mediated inhibition of MTOR activity. mTORC2 is also activated by growth factors, but seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'..
Protein Sequence MNTSPGTVGSDPVILATAGYDHTVRFWQAHSGICTRTVQHQDSQVNALEVTPDRSMIAAAGYQHIRMYDLNSNNPNPIISYDGVNKNIASVGFHEDGRWMYTGGEDCTARIWDLRSRNLQCQRIFQVNAPINCVCLHPNQAELIVGDQSGAIHIWDLKTDHNEQLIPEPEVSITSAHIDPDASYMAAVNSTGNCYVWNLTGGIGDEVTQLIPKTKIPAHTRYALQCRFSPDSTLLATCSADQTCKIWRTSNFSLMTELSIKSGNPGESSRGWMWGCAFSGDSQYIVTASSDNLARLWCVETGEIKREYGGHQKAVVCLAFNDSVLG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1 (in isoform 4)Acetylation-12.7719369195
1Acetylation-------MNTSPGTV
-------CCCCCCCC
12.7719369195
3Phosphorylation-----MNTSPGTVGS
-----CCCCCCCCCC
34.6925159151
4Phosphorylation----MNTSPGTVGSD
----CCCCCCCCCCC
19.1425159151
7Phosphorylation-MNTSPGTVGSDPVI
-CCCCCCCCCCCCEE
25.6930108239
7 (in isoform 4)Phosphorylation-25.6917192257
10PhosphorylationTSPGTVGSDPVILAT
CCCCCCCCCCEEEEE
34.1130108239
12 (in isoform 4)Phosphorylation-19.4224247654
17PhosphorylationSDPVILATAGYDHTV
CCCEEEEECCCCCHH
19.7126074081
19 (in isoform 4)Phosphorylation-24.8518691976
20PhosphorylationVILATAGYDHTVRFW
EEEEECCCCCHHEEH
11.3326074081
20 (in isoform 3)Ubiquitination-11.3321906983
23PhosphorylationATAGYDHTVRFWQAH
EECCCCCHHEEHHHC
15.5224425749
37PhosphorylationHSGICTRTVQHQDSQ
CCCCCEEEEECCCCC
13.3320873877
43PhosphorylationRTVQHQDSQVNALEV
EEEECCCCCCCEEEE
29.4720873877
51PhosphorylationQVNALEVTPDRSMIA
CCCEEEECCCHHHHH
15.3126091039
55PhosphorylationLEVTPDRSMIAAAGY
EEECCCHHHHHHHCC
23.17-
62PhosphorylationSMIAAAGYQHIRMYD
HHHHHHCCCEEEEEE
7.6829496907
85UbiquitinationIISYDGVNKNIASVG
CEEECCCCCCEEEEE
36.8721963094
86 (in isoform 1)Ubiquitination-47.5321906983
86UbiquitinationISYDGVNKNIASVGF
EEECCCCCCEEEEEE
47.532190698
92UbiquitinationNKNIASVGFHEDGRW
CCCEEEEEEEECCCE
18.7221963094
101PhosphorylationHEDGRWMYTGGEDCT
EECCCEEEECCCCCC
8.6929496907
105 (in isoform 4)Ubiquitination-51.7821906983
111UbiquitinationGEDCTARIWDLRSRN
CCCCCEEHHHHHHCC
2.8821963094
141UbiquitinationVCLHPNQAELIVGDQ
EEECCCCEEEEEECC
21.8721963094
149UbiquitinationELIVGDQSGAIHIWD
EEEEECCCCCEEEEE
34.6321963094
157UbiquitinationGAIHIWDLKTDHNEQ
CCEEEEECCCCCCCC
3.7521963094
163UbiquitinationDLKTDHNEQLIPEPE
ECCCCCCCCCCCCCC
43.2621963094
179UbiquitinationSITSAHIDPDASYMA
EEEEEEECCCCCCEE
25.7621963094
195UbiquitinationVNSTGNCYVWNLTGG
EECCCCEEEEECCCC
16.7021963094
201UbiquitinationCYVWNLTGGIGDEVT
EEEEECCCCCCHHHH
28.9621963094
214PhosphorylationVTQLIPKTKIPAHTR
HHHCCCCCCCCCCCE
28.9320068231
214UbiquitinationVTQLIPKTKIPAHTR
HHHCCCCCCCCCCCE
28.9321963094
215UbiquitinationTQLIPKTKIPAHTRY
HHCCCCCCCCCCCEE
53.4721963094
221UbiquitinationTKIPAHTRYALQCRF
CCCCCCCEEEEEEEC
12.5921963094
222PhosphorylationKIPAHTRYALQCRFS
CCCCCCEEEEEEECC
16.90-
239UbiquitinationSTLLATCSADQTCKI
CEEEEECCCCCCCEE
30.4421963094
240UbiquitinationTLLATCSADQTCKIW
EEEEECCCCCCCEEE
18.3121963094
244UbiquitinationTCSADQTCKIWRTSN
ECCCCCCCEEEEECC
2.2121963094
245UbiquitinationCSADQTCKIWRTSNF
CCCCCCCEEEEECCC
49.0021963094
249PhosphorylationQTCKIWRTSNFSLMT
CCCEEEEECCCEEEE
17.0228509920
250PhosphorylationTCKIWRTSNFSLMTE
CCEEEEECCCEEEEE
27.5728509920
251UbiquitinationCKIWRTSNFSLMTEL
CEEEEECCCEEEEEE
29.8821963094
259PhosphorylationFSLMTELSIKSGNPG
CEEEEEEEECCCCCC
23.0329083192
260UbiquitinationSLMTELSIKSGNPGE
EEEEEEEECCCCCCC
6.8621963094
261UbiquitinationLMTELSIKSGNPGES
EEEEEEECCCCCCCC
49.2721963094
267UbiquitinationIKSGNPGESSRGWMW
ECCCCCCCCCCCEEE
46.9621963094
270UbiquitinationGNPGESSRGWMWGCA
CCCCCCCCCEEEEEE
52.6621963094
286UbiquitinationSGDSQYIVTASSDNL
CCCCCEEEEECCCCE
2.8921963094
304UbiquitinationWCVETGEIKREYGGH
EEEECCCEEHHHCCC
5.5821963094
305UbiquitinationCVETGEIKREYGGHQ
EEECCCEEHHHCCCC
34.5721963094
305SumoylationCVETGEIKREYGGHQ
EEECCCEEHHHCCCC
34.57-
311UbiquitinationIKREYGGHQKAVVCL
EEHHHCCCCCEEEEE
22.9321963094
330UbiquitinationSVLG-----------
CCCC-----------
21963094

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseTANKQ92844
PMID:28489822

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LST8_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LST8_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MTOR_HUMANMTORphysical
20562859
RPTOR_HUMANRPTORphysical
20562859
KRT85_HUMANKRT85physical
20562859
TCPB_HUMANCCT2physical
20562859
SQSTM_HUMANSQSTM1physical
21981924
MTOR_HUMANMTORphysical
12718876
ANM1_HUMANPRMT1physical
23455924
4EBP1_HUMANEIF4EBP1physical
18955708
RPTOR_HUMANRPTORphysical
12408816
MTOR_HUMANMTORphysical
12408816
TCPH_HUMANCCT7physical
26186194
MTOR_HUMANMTORphysical
26186194
TCPW_HUMANCCT6Bphysical
26186194
TCPB_HUMANCCT2physical
26186194
THIC_HUMANACAT2physical
26186194
SETX_HUMANSETXphysical
26186194
PRAME_HUMANPRAMEphysical
26186194
TBA1A_HUMANTUBA1Aphysical
26186194
PFD5_HUMANPFDN5physical
26186194
FOXF2_HUMANFOXF2physical
26186194
ETV3_HUMANETV3physical
26186194
LYPA2_HUMANLYPLA2physical
26186194
KEAP1_HUMANKEAP1physical
26186194
MELK_HUMANMELKphysical
26186194
WDR60_HUMANWDR60physical
26186194
UBP54_HUMANUSP54physical
26186194
MTOR_HUMANMTORphysical
28514442
LYPA2_HUMANLYPLA2physical
28514442
PRAME_HUMANPRAMEphysical
28514442
TCPH_HUMANCCT7physical
28514442
THIC_HUMANACAT2physical
28514442
FOXF2_HUMANFOXF2physical
28514442
TCPB_HUMANCCT2physical
28514442
TBA4A_HUMANTUBA4Aphysical
28514442
TCPG_HUMANCCT3physical
28514442
TCPW_HUMANCCT6Bphysical
28514442
MELK_HUMANMELKphysical
28514442
RICTR_HUMANRICTORphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LST8_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-4 AND THR-7,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7 (ISOFORM 3), AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT SER-7 (ISOFORM 3), AND MASS SPECTROMETRY.

TOP